Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Northeast Scientific.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, B.More, Bridgebio, Hookipa, Lepu, Matinas, Medexus, Qbiotics, Veru.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acufocus.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acticor, Alnylam, Ascentage, Astellas, Aurinia, Bavarian Nordic, Bristol Myers Squibb, Genentech, Genfleet, Gilead, Janssen, Moderna, Rhythm, Roche, Seagen, Zelira.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Irthythm, Verily.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Incannex, Junshi, Karyopharm, NLS, Obsidian, Olema, Pliant, Recursion, Sandoz, Sangamo.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Healthy.io, Nugen, Rapidai.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ascentage, Belite, Celcuity, Daewoong, Eiger, Genmab, Karyopharm, Novavax, Oncopeptides, Peptilogics, Poolbeg, PTC, Qu, Rheos, Rhythm, Samsung, Soleno, Sorrento, Vivus, Wugen.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acadia, Apellis, Astrazeneca, Avadel, Daiichi, Destiny, Gilead, Incyte, Moderna, Viking.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Ascentage, Astrazeneca, Daewoong, Daiichi Sankyo, Genfleet, Gilead Sciences, Incannex Healthcare, Innovent, Junshi, Moderna, Novavax, Qu, Samsung Bioepis, Sorrento.